The Approach
Today,due to the very low proportion of platelets in the blood and to the complexity of this long and multi steps centrifuge-based manufacturing process,Blood Banks world wide struggle to produce Platelets Concentrates with affordable pricing complying with high level regulatory mandatories. Indeed,Accoustophoresis allows a much softer processing(6 times below shear stress platelets’ activation threshold) than centrifuge methods,and thus to achieve a more efficient sorting and a expected better quality and preservation.
Thus,platelets transfusions are needed to treat “thrombocytopenia” which is a decrease in platelet concentration that is induced by a large number of diseases,many with a rising incidence due to population ageing,such as autoimmune diseases,hematologic malignancies,bone marrow suppression,side effects of heparin based treatment,haemophiliac patients,sickle cell disease,thalassemia,traumas and injuries. In most of countries,over 80% of platelets extraction are proceed by Blood Bank from Whole Blood donations.